Todd Pletcher's seven-day suspension began Tuesday, but the immediate racing impact is limited: horses already entered under his name at Belmont Park and Gulfstream Park remain eligible to run. The penalty follows a betamethasone finding in Weetamoo after the filly's nine-length maiden victory at Keeneland on April 17. BloodHorse reported that the Horseracing Integrity and Welfare Unit also assigned Pletcher 1.5 penalty points.
The official resolution disqualifies Weetamoo from the Keeneland race and requires Blue Bird Stables to surrender the $50,724 winner's share. Pletcher must pay a $1,000 fine, and his suspension runs for seven days under the Horseracing Integrity and Safety Authority's medication-control system. Entries made before the suspension took effect are allowed to stand, which explains why Pletcher's already-listed horses were not scratched. Paulick Report's account placed the ruling on HIWU's resolutions portal Nov. 9.
The case is a regulatory setback, but not a claim that Weetamoo's performance was fueled by a prohibited performance-enhancing drug. Betamethasone is an FDA-approved corticosteroid used in equine medicine to reduce inflammation and manage pain, while racing rules impose strict withdrawal and threshold requirements. Pletcher's attorney, Drew Mollica, told Thoroughbred Daily News that the stable believed the medication had been administered within the guidelines, but accepted the result and chose not to appeal.
That decision matters because the timing leaves the stable facing the financial consequence months after the race while Weetamoo's form has effectively gone dormant. The filly has not started since Keeneland; her only reported follow-up activity came in two Belmont workouts in May, according to the published coverage. For handicappers, the nine-length victory is therefore unusable as a current-form anchor: the purse and official win are gone, and there is no subsequent race to show whether the performance represented genuine ability or a short-lived peak.
Pletcher's suspension also arrives against a backdrop of heightened scrutiny over therapeutic medications. Betamethasone was central to the disqualification of Medina Spirit from the 2021 Kentucky Derby, although the present matter is a separate case involving a different horse, trainer and set of circumstances. The practical lesson for Pletcher's barn is straightforward: even a medication permitted for therapeutic use can trigger a violation when residue remains above the applicable limit. With no appeal planned, the Weetamoo ruling now stands as a costly administrative loss rather than an extended courtroom fight.